HILS Stock Price, News & Analysis

hils NASDAQ

Company Description

HILS (NASDAQ: hils) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

hils stock has gained 613.1% over the past year.

This page provides a comprehensive overview of hils stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+613.11%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

HILS (hils) stock. Over the past 12 months, the stock has gained 613.1%.

Latest News

View All

September 4, 2025

0.00%

Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl

conferences

November 6, 2023

+61.49%

Tharimmune Executes Exclusive Global Licensing Agreement for Innovative Clinical Stage Asset for Chronic Pruritis

September 22, 2023

+2.76%

Hillstream BioPharma Progressing Towards Acquiring Clinical Stage Asset and Announces Corporate Name Change to Tharimmune, Inc.

acquisition

September 11, 2023

-8.12%

Hillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic Pruritis

acquisition

September 8, 2023

-3.43%

Hillstream BioPharma to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13

conferences

August 9, 2023

-3.64%

Hillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference on August 16-17, 2023

conferences

HILS has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, acquisition, management. View all hils news →

SEC Filings

View All

No SEC filings available for hils.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

hils Company Profile & Sector Positioning

HILS (hils) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.